Lonza to get $2bn acquisition loan as IG loan pricing remains immune to crisis
Citi, Credit Suisse and JP Morgan are arranging around $2bn of loans for Swiss life sciences company Lonza’s acquisition of Arch Chemicals, the US microbial control business. The loan comes as the western European investment grade market shows no evidence of having been affected by the eurozone sovereign debt crisis.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
